DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Ohtake Y, Sato T, Kobayashi T et al.
Discovery of tofogliflozin, a novel C-arylglucoside with an O-spiroketal ring system, as a highly selective sodium glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.
J Med Chem 2012;
55: 7828-7840
We do not assume any responsibility for the contents of the web pages of other providers.